Dengue Epidemic: Urgent Action Needed
The Americas face a critical public health challenge: a dramatic surge in dengue fever cases signals a worsening epidemic. Unprecedented infection rates plague Paraguay and Bolivia, and other nations are registering steep increases. Amidst the raging COVID-19 pandemic, these escalating dengue infections threaten to overwhelm healthcare systems and, experts fear, are leading to critical underreporting. This crisis is affecting North America, too, with rising numbers. Health officials struggle to treat both illnesses concurrently. For thorough updates, News Directory 3 is your source. What steps will be taken to combat this double threat? Discover what’s next.
Dengue Fever cases Rise Sharply Across the Americas
Updated May 30, 2025
The Americas are grappling with a surge in dengue fever cases, prompting concern from health officials. The CDC reported unusually high numbers across the region, with Argentina approaching its 2016 record of 80,000 cases. This spike follows a record-breaking year in 2019, when over 3.1 million cases and 1,500 deaths were reported, according to the Pan American Health Organization (PAHO).
Paraguay and Bolivia are experiencing especially severe outbreaks. Paraguay has reported nearly 220,000 infections, 50 times more than the same period in 2019. Bolivia’s 83,000 cases are almost ten times higher than 2019 figures. Argentina has also seen a dramatic increase,with 72,701 dengue infections and 24 deaths,dwarfing previous years.
While Brazil is experiencing fewer cases compared to last year, other countries, including belize, Colombia, Costa Rica, Dominican Republic, El Salvador, Guadeloupe, Guatemala, honduras, Mexico, Nicaragua, Peru, and Saint Martin, are seeing increases. Even North America is affected, with Miami-Dade County reporting Florida’s first locally acquired case of the year, according to CBS Miami.
The ongoing COVID-19 pandemic may be exacerbating the situation. Euractiv reports that Latin America is a major COVID-19 hotspot, perhaps straining healthcare resources and limiting access to treatment for dengue fever patients.
“All three of us had dengue, we had all the symptoms, the pain, the rash, but we didn’t go to a clinic or a health center so as not to expose ourselves [to COVID-19],”
Sonia Fernandez, a Paraguayan lawyer, told Reuters that she and her daughters avoided seeking medical care for dengue symptoms due to COVID-19 fears. This reluctance to seek treatment may lead to underreporting, as Esteban Ortiz, a global health researcher, explained to Reuters. He noted that while cases haven’t decreased, diagnoses have.
What’s next
While border closures and flight restrictions related to COVID-19 may be slowing the spread of dengue,the long-term impact of the pandemic on dengue prevention and treatment remains a concern. Public health officials are urged to address both crises concurrently to mitigate the impact on vulnerable populations.